eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal for a Female patient aged 39

This is a personalized study for a 39 year old female patient. The study is created by eHealthMe based on reports of 3 people who take the same drugs and have drug interactionsfrom FDA.

On Oct, 29, 2014: 3 people who reported to have interactions when taking Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal are studied

Trend of Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal's drug interactions, side effects, and effectiveness reports (2546073)

Information of the patient in this study:

Age: 39

Gender: female

Conditions: Hepatitis C, Insomnia, Depression

Drugs taking:
- Ribapak
- Remeron
- Pegasys
- Isopropyl Alcohol Compound Liquid
- Pseudoephedrine Hcl
- Methamphetamine Hydrochloride
- Lexapro
- Buspar
- Prilosec
- Risperdal

Drug interactions have: Anxiety, Fatigue, Pain, Therapeutic Agent Toxicity, Treatment Noncompliance

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 39 (±5):

InteractionNumber of reports
Anxiety2 (100.00%)
Fatigue (feeling of tiredness)2 (100.00%)
Pain2 (100.00%)
Therapeutic Agent Toxicity (poisoning by ability to cure substance)2 (100.00%)
Treatment Noncompliance2 (100.00%)

Most common interactions experienced by females aged 39 (±5) in the use of Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal:

InteractionNumber of reports
Pain2
Fatigue (feeling of tiredness)2
Anxiety2
Drug Toxicity2
Treatment Noncompliance2
Therapeutic Agent Toxicity (poisoning by ability to cure substance)2

Most common interactions experienced by females aged 39 (±5) in long term use of Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Anxiety3 (100.00%)
Fatigue (feeling of tiredness)3 (100.00%)
Pain3 (100.00%)
Therapeutic Agent Toxicity (poisoning by ability to cure substance)2 (66.67%)
Treatment Noncompliance3 (100.00%)

Most common interactions experienced by people in the use of Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal:

InteractionNumber of reports
Pain3
Fatigue (feeling of tiredness)3
Anxiety3
Treatment Noncompliance3
Drug Toxicity3
Therapeutic Agent Toxicity (poisoning by ability to cure substance)2

Most common interactions experienced by people in long term use of Ribapak, Remeron, Pegasys, Isopropyl Alcohol Compound Liquid, Pseudoephedrine Hcl, Methamphetamine Hydrochloride, Lexapro, Buspar, Prilosec, Risperdal:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.